PL1799253T3 - Wieloważna szczepionka dla psów przeciwko Leptospira bratislava i innym patogenom - Google Patents
Wieloważna szczepionka dla psów przeciwko Leptospira bratislava i innym patogenomInfo
- Publication number
- PL1799253T3 PL1799253T3 PL05789769T PL05789769T PL1799253T3 PL 1799253 T3 PL1799253 T3 PL 1799253T3 PL 05789769 T PL05789769 T PL 05789769T PL 05789769 T PL05789769 T PL 05789769T PL 1799253 T3 PL1799253 T3 PL 1799253T3
- Authority
- PL
- Poland
- Prior art keywords
- canine
- caused
- leptospira
- pathogens
- methods
- Prior art date
Links
- 241000589902 Leptospira Species 0.000 title abstract 5
- 241000282465 Canis Species 0.000 title abstract 4
- 229960005486 vaccine Drugs 0.000 title abstract 4
- 244000052769 pathogen Species 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 4
- 241000282472 Canis lupus familiaris Species 0.000 abstract 3
- 208000000655 Distemper Diseases 0.000 abstract 3
- 208000014058 canine distemper Diseases 0.000 abstract 3
- 201000010099 disease Diseases 0.000 abstract 3
- 241000588779 Bordetella bronchiseptica Species 0.000 abstract 2
- 241000701101 Canine adenovirus 1 Species 0.000 abstract 2
- 241000701114 Canine adenovirus 2 Species 0.000 abstract 2
- 241000711506 Canine coronavirus Species 0.000 abstract 2
- 241000701931 Canine parvovirus Species 0.000 abstract 2
- 208000004467 Infectious Canine Hepatitis Diseases 0.000 abstract 2
- 208000002606 Paramyxoviridae Infections Diseases 0.000 abstract 2
- 241000700605 Viruses Species 0.000 abstract 2
- 208000004232 Enteritis Diseases 0.000 abstract 1
- 241001550390 Leptospira interrogans serovar Canicola Species 0.000 abstract 1
- 241001518154 Leptospira kirschneri serovar Grippotyphosa Species 0.000 abstract 1
- 206010024238 Leptospirosis Diseases 0.000 abstract 1
- 206010044314 Tracheobronchitis Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000002458 infectious effect Effects 0.000 abstract 1
- 208000023504 respiratory system disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/23—Parvoviridae, e.g. feline panleukopenia virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/099—Bordetella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A61K39/175—Canine distemper virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/235—Adenoviridae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14311—Parvovirus, e.g. minute virus of mice
- C12N2750/14334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
- C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/959,757 US20050089533A1 (en) | 2003-01-29 | 2004-10-06 | Canine vaccines against Bordetella bronchiseptica |
| PCT/IB2005/003111 WO2006038115A1 (en) | 2004-10-06 | 2005-09-23 | Multivalent canine vaccines against leptospira bratislava and other pathogens |
| EP05789769A EP1799253B1 (en) | 2004-10-06 | 2005-09-23 | Multivalent canine vaccines against leptospira bratislava and other pathogens |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1799253T3 true PL1799253T3 (pl) | 2012-01-31 |
Family
ID=35657262
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL05789769T PL1799253T3 (pl) | 2004-10-06 | 2005-09-23 | Wieloważna szczepionka dla psów przeciwko Leptospira bratislava i innym patogenom |
Country Status (26)
| Country | Link |
|---|---|
| US (2) | US20050089533A1 (pl) |
| EP (1) | EP1799253B1 (pl) |
| JP (2) | JP4163245B2 (pl) |
| KR (3) | KR101226869B1 (pl) |
| CN (2) | CN101791398A (pl) |
| AT (1) | ATE524193T1 (pl) |
| AU (1) | AU2005290921C1 (pl) |
| BR (1) | BRPI0516253A (pl) |
| CA (1) | CA2583689C (pl) |
| CY (1) | CY1114897T1 (pl) |
| DK (1) | DK1799253T3 (pl) |
| ES (1) | ES2370750T3 (pl) |
| FR (2) | FR14C0079I1 (pl) |
| LU (2) | LU92135I2 (pl) |
| ME (1) | ME01306B (pl) |
| MX (1) | MX2007004133A (pl) |
| NO (1) | NO20071385L (pl) |
| NZ (3) | NZ576898A (pl) |
| PL (1) | PL1799253T3 (pl) |
| PT (1) | PT1799253E (pl) |
| RS (1) | RS52035B (pl) |
| RU (1) | RU2400248C2 (pl) |
| SI (1) | SI1799253T1 (pl) |
| UA (1) | UA91197C2 (pl) |
| WO (1) | WO2006038115A1 (pl) |
| ZA (1) | ZA200702166B (pl) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050089533A1 (en) * | 2003-01-29 | 2005-04-28 | Joseph Frantz | Canine vaccines against Bordetella bronchiseptica |
| NZ566490A (en) * | 2005-10-07 | 2011-06-30 | Pfizer Prod Inc | Live attenuated or killed H3N8 influenza vaccines and methods to treat canine influenza |
| US7468187B2 (en) * | 2005-10-18 | 2008-12-23 | Iowa State University Research Foundation, Inc. | Canine influenza virus and related compositions and methods of use |
| US7682619B2 (en) * | 2006-04-06 | 2010-03-23 | Cornell Research Foundation, Inc. | Canine influenza virus |
| EP2062972A4 (en) * | 2006-09-13 | 2010-11-24 | Nippon Zenyaku Kogyo Co Ltd | NEW DOG VACCINE |
| BRPI0719360B1 (pt) * | 2006-11-03 | 2016-09-06 | Intervet Int Bv | vacina da doença de lyme canina, e, uso de organismos de uma genoespécie de borrelia |
| HUE062920T2 (hu) * | 2006-12-27 | 2023-12-28 | Zoetis Services Llc | Eljárások vakcina beadására |
| AU2015255165A1 (en) * | 2006-12-27 | 2015-11-26 | Zoetis Services Llc | Methods of vaccine administration |
| PT2134742E (pt) | 2007-02-27 | 2012-09-06 | Wyeth Llc | Métodos e composições imunogénicas para tratar e prevenir infecções em animais |
| US7878586B2 (en) * | 2007-10-29 | 2011-02-01 | The Boeing Company | System and method for an anticipatory passenger cabin |
| RU2440137C1 (ru) * | 2007-12-21 | 2012-01-20 | Пфайзер Инк. | Термообработанные бактерины и эмульсионные вакцины, полученные из таких термообработанных бактеринов |
| RU2015113826A (ru) * | 2009-10-14 | 2015-09-20 | Дзе Борд Оф Риджентс Фор Оклахома Стейт Юниверсити | Выделение вируса, родственного парвовирусу-2 собак, от енота |
| CN103153337A (zh) | 2010-09-28 | 2013-06-12 | 共立制药股份有限公司 | 黏膜佐剂组合物 |
| PT2670432T (pt) * | 2011-02-04 | 2021-05-04 | Zoetis Services Llc | Composições imunogénicas de bordetella bronchiseptica |
| CN103596588B (zh) * | 2011-02-04 | 2016-02-03 | 佐蒂斯有限责任公司 | 用于犬呼吸道疾病综合征的组合物 |
| CN102343088B (zh) * | 2011-10-14 | 2013-02-13 | 浙江诺倍威生物技术有限公司 | 一种犬传染性气管支气管炎二联活疫苗及其制备方法 |
| PT2884996T (pt) * | 2012-08-17 | 2020-02-21 | Intervet Int Bv | Uma composição imunogénica de bactérias de leptospira mortas |
| EP2884997B1 (en) | 2012-08-17 | 2020-01-22 | Intervet International B.V. | An immunogenic composition of killed leptospira bacteria |
| US9314519B2 (en) * | 2012-08-21 | 2016-04-19 | Intervet Inc. | Liquid stable virus vaccines |
| CZ307883B6 (cs) * | 2013-01-29 | 2019-07-24 | Bioveta, A.S. | Multivalentní vakcína k imunoprofylaxi infekčních onemocnění psů |
| RU2546247C2 (ru) * | 2013-06-06 | 2015-04-10 | Автономная некоммерческая организация "Научно-исследовательский институт диагностики и профилактики болезней человека и животных" (АНО "НИИ ДПБ") | Вакцина против чумы, аденовирусных инфекций, парвовирусного и коронавирусного энтеритов, лептоспироза и бешенства собак |
| KR101622554B1 (ko) | 2014-07-16 | 2016-05-19 | (주)양성그린바이오 | 면역항체를 이용한 강아지질병의 치료용 조성물의 제조방법 |
| EP3909971A1 (en) | 2020-09-28 | 2021-11-17 | Institute of Life Sciences (ILS) | Whole cell livestock vaccine for respiratory diseases |
| CN117187118B (zh) * | 2023-08-16 | 2024-07-23 | 华中农业大学 | 一株支气管败血波氏杆菌a1218及其应用 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3470294A (en) * | 1961-06-21 | 1969-09-30 | Behringwerke Ag | Vaccine for immunization of dogs and foxes against distemper,hepatitis contagiosa and leptospirosis and process for preparing it |
| US4567042A (en) * | 1983-06-15 | 1986-01-28 | American Home Products Corporation | Inactivated canine coronavirus vaccine |
| US4567043A (en) * | 1983-06-15 | 1986-01-28 | American Home Products Corporation (Del.) | Canine corona virus vaccine |
| US4888169A (en) * | 1986-10-14 | 1989-12-19 | Norden Laboratories, Inc. | Bordetella Bronchiseptica vaccine |
| RU2030915C1 (ru) * | 1990-10-31 | 1995-03-20 | Всероссийский государственный научно-исследовательский институт контроля, стандартизации и сертификации ветеринарных препаратов | Вакцина против лептоспироза животных |
| JP2521226B2 (ja) * | 1993-01-28 | 1996-08-07 | 株式会社微生物化学研究所 | 犬用多種混合ワクチン |
| JPH08508980A (ja) * | 1993-03-31 | 1996-09-24 | ザ リージェンツ オブ ザ ユニバーシティー オブ カリフォルニア | クローン化レプトスピラ外膜タンパク質 |
| UA56132C2 (uk) * | 1995-04-25 | 2003-05-15 | Смітклайн Бічем Байолоджікалс С.А. | Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини |
| AUPO549497A0 (en) * | 1997-03-07 | 1997-03-27 | Agriculture Victoria Services Pty Ltd | Novel bacterial pathogens |
| US6306623B1 (en) * | 1998-02-24 | 2001-10-23 | The University Of California | Leptospiral major outer membrane protein LipL32 |
| NZ501213A (en) * | 1998-12-22 | 2001-09-28 | Pfizer Prod Inc | Isolated leptospira membrane kinase, membrane permease, membrane mannosyltransferase and endoflagellin proteins for preventing leptospirosis |
| US20020058039A1 (en) * | 2000-04-27 | 2002-05-16 | Coyne Michael J. | Method of measuring the duration of adequate immune memory in companion animals |
| US20030129161A1 (en) * | 2001-09-17 | 2003-07-10 | Hsien-Jue Chu | Interleukin-12 as a veterinary vaccine adjuvant |
| CA2486345C (en) * | 2002-05-17 | 2012-08-14 | Fundacao Oswaldo Cruz - Fiocruz | Proteins with repetitive bacterial-ig-like (big) domains present in leptospira species |
| NZ538394A (en) * | 2002-08-26 | 2008-06-30 | Pfizer Prod Inc | Vaccine for respiratory and reproductive system infections in cattles |
| HRP20050660A2 (en) * | 2003-01-29 | 2006-02-28 | Pfizer Products Inc. | Canine vaccines against bordetella bronchiseptica |
| US20050089533A1 (en) * | 2003-01-29 | 2005-04-28 | Joseph Frantz | Canine vaccines against Bordetella bronchiseptica |
| HUE062920T2 (hu) * | 2006-12-27 | 2023-12-28 | Zoetis Services Llc | Eljárások vakcina beadására |
-
2004
- 2004-10-06 US US10/959,757 patent/US20050089533A1/en not_active Abandoned
-
2005
- 2005-09-23 KR KR1020127000574A patent/KR101226869B1/ko not_active Expired - Lifetime
- 2005-09-23 ME MEP-2011-192A patent/ME01306B/me unknown
- 2005-09-23 BR BRPI0516253-0A patent/BRPI0516253A/pt not_active Application Discontinuation
- 2005-09-23 RU RU2007112480/13A patent/RU2400248C2/ru active
- 2005-09-23 CA CA2583689A patent/CA2583689C/en not_active Expired - Lifetime
- 2005-09-23 DK DK05789769.6T patent/DK1799253T3/da active
- 2005-09-23 PL PL05789769T patent/PL1799253T3/pl unknown
- 2005-09-23 AT AT05789769T patent/ATE524193T1/de active
- 2005-09-23 KR KR1020087025748A patent/KR20080096610A/ko not_active Ceased
- 2005-09-23 RS RS20110497A patent/RS52035B/sr unknown
- 2005-09-23 SI SI200531376T patent/SI1799253T1/sl unknown
- 2005-09-23 CN CN200910226561A patent/CN101791398A/zh active Pending
- 2005-09-23 NZ NZ576898A patent/NZ576898A/en not_active Application Discontinuation
- 2005-09-23 EP EP05789769A patent/EP1799253B1/en not_active Revoked
- 2005-09-23 KR KR1020077008111A patent/KR20070050499A/ko not_active Ceased
- 2005-09-23 CN CN2005800341946A patent/CN101035558B/zh not_active Expired - Lifetime
- 2005-09-23 MX MX2007004133A patent/MX2007004133A/es active IP Right Grant
- 2005-09-23 NZ NZ553867A patent/NZ553867A/en not_active Application Discontinuation
- 2005-09-23 PT PT05789769T patent/PT1799253E/pt unknown
- 2005-09-23 UA UAA200703828A patent/UA91197C2/ru unknown
- 2005-09-23 ES ES05789769T patent/ES2370750T3/es not_active Expired - Lifetime
- 2005-09-23 WO PCT/IB2005/003111 patent/WO2006038115A1/en not_active Ceased
- 2005-09-23 NZ NZ591422A patent/NZ591422A/xx not_active Application Discontinuation
- 2005-09-23 AU AU2005290921A patent/AU2005290921C1/en not_active Expired
- 2005-09-23 JP JP2007535271A patent/JP4163245B2/ja not_active Expired - Lifetime
-
2007
- 2007-03-14 ZA ZA200702166A patent/ZA200702166B/xx unknown
- 2007-03-15 NO NO20071385A patent/NO20071385L/no unknown
- 2007-12-21 US US11/962,699 patent/US20080175860A1/en not_active Abandoned
-
2008
- 2008-04-15 JP JP2008105332A patent/JP2008239627A/ja active Pending
-
2011
- 2011-10-17 CY CY20111100986T patent/CY1114897T1/el unknown
-
2013
- 2013-01-16 LU LU92135C patent/LU92135I2/fr unknown
- 2013-01-16 LU LU92136C patent/LU92136I2/fr unknown
-
2014
- 2014-11-07 FR FR14C0079C patent/FR14C0079I1/fr active Active
- 2014-11-07 FR FR14C0078C patent/FR14C0078I1/fr active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200702166B (en) | Multivalent canine vaccines against leptospira bratislava and other pathogens | |
| TW200505476A (en) | Canine vaccines against bordetella bronchiseptica | |
| HRP20050192B1 (hr) | Cjepivo za infekcije dišnog i spolnog sustava kod goveda | |
| IL131678A0 (en) | An immunological composition comprising a borrelia burgdorferi antigen and its use | |
| WO2004093904A3 (en) | Modified live vaccines comprising bhv-1(ibr) and/or bvdv pregnant and nursing cattles | |
| AR070675A1 (es) | Bacterinas tratadas termicamente y vacunas de emulsion preparadas a partir de tales bacterinas tratadas termicamente | |
| RU2009120894A (ru) | Вакцина против лаймской болезни собак | |
| WO2008106393A3 (en) | Immunogenic compositions and methods for treating and preventing animal infections | |
| PH12013501607A1 (en) | Compositions for canine respiratory disease complex | |
| AU3887695A (en) | Interleukin-12 as an adjuvant for paramyxoviridae vaccines | |
| TH71070A (th) | วัคซีนสุนัขต้าน Bordetella bronchiseptica | |
| TH104750A (th) | แบคทีรินที่กระทำด้วยความร้อน และวัคซีนอีมัลชันที่ได้รับการเตรียมจากแบคทีรินที่กระทำด้วยความร้อนดังกล่าว | |
| RU2025101109A (ru) | Вакцина для защиты против leptospira серовара australis | |
| RU2025101113A (ru) | Вакцина для защиты против leptospira серовара grippotyphosa | |
| CO5690616A2 (es) | Vacunas para enfermedades reproductoras del ganado | |
| World Health Organization | United Nations [UN] prequalified vaccines | |
| HE et al. | Acute Ammonia Poisoning: Roentgenographic Features of Chest | |
| LUO et al. | Contribution of radiogram in diagnosis of primary vertical root fracture in mandibular first molar | |
| Devlin | Leslie Spence. Recipient of the Canadian Association of Medical Microbiology Founder's Award for 1999 | |
| LIU et al. | Application of LeFort I osteotomy in the treatment of old maxillary fracture | |
| TH63878B (th) | องค์ประกอบก่อภูมิคุ้มกัน pcv2 ชนิดมัลติเวเลนต์ และวิธีของการผลิตองค์ประกอบเหล่านี้ |